Mark Stephen Johnson, MD | |
620 John Paul Jones Cir, Portsmouth, VA 23708-2111 | |
(757) 953-2154 | |
Not Available |
Full Name | Mark Stephen Johnson |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 18 Years |
Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235142357 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 2015-00091 (North Carolina) | Secondary |
208600000X | Surgery | 0101248712 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Chesapeake Regional Medical Center | Chesapeake, VA | Hospital |
Sentara Obici Hospital | Suffolk, VA | Hospital |
Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Chesapeake Regional Medical Group | 8426113663 | 98 |
Sentara Medical Group | 8921903923 | 1058 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).
In a recent scientific study just published in the Journal of Applied Physiology, Bangsbo and co-workers demonstrate that by reducing the volume of training by 25% and introducing the so-called speed endurance training (6-12 30-s sprint runs 3-4 times a week), endurance trained runners can improve not only short-term but also long-term performance.
Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, today announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.
› Verified 1 days ago
Entity Name | Sentara Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).
In a recent scientific study just published in the Journal of Applied Physiology, Bangsbo and co-workers demonstrate that by reducing the volume of training by 25% and introducing the so-called speed endurance training (6-12 30-s sprint runs 3-4 times a week), endurance trained runners can improve not only short-term but also long-term performance.
Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, today announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.
› Verified 1 days ago
Entity Name | Chesapeake Regional Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699940270 PECOS PAC ID: 8426113663 Enrollment ID: O20090223000187 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).
In a recent scientific study just published in the Journal of Applied Physiology, Bangsbo and co-workers demonstrate that by reducing the volume of training by 25% and introducing the so-called speed endurance training (6-12 30-s sprint runs 3-4 times a week), endurance trained runners can improve not only short-term but also long-term performance.
Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, today announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mark Stephen Johnson, MD 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (757) 953-2154 | Mark Stephen Johnson, MD 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (757) 953-2154 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours.
Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).
In a recent scientific study just published in the Journal of Applied Physiology, Bangsbo and co-workers demonstrate that by reducing the volume of training by 25% and introducing the so-called speed endurance training (6-12 30-s sprint runs 3-4 times a week), endurance trained runners can improve not only short-term but also long-term performance.
Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, today announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.
› Verified 1 days ago
Dr. Shelley Kathleen Perkins, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir Dept General, Portsmouth, VA 23708 Phone: 443-510-5264 | |
Dr. Francis Patrick Cuozzo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-5008 | |
Dr. Hilary Mckinley, DO Surgery Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 | |
Lauren Daugherty, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 | |
Dr. Susan Christine Clark, MD Surgery Medicare: Medicare Enrolled Practice Location: Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 757-953-9759 Fax: 757-953-0845 | |
Jonathan L Halbach, D.O. Surgery Medicare: Medicare Enrolled Practice Location: Nmrtc Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 757-953-2446 | |
Dr. Daniel Paul Sanford, DO Surgery Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |